DNP, mitochondrial uncoupling, and neuroprotection: A little dab'll do ya

Alzheimer's and Dementia

Volumn 13, Issue 5, 2017, Pages 582-591

  Geisler, John G ^a   Marosi, Krisztina ^b   Halpern, Joshua ^b   Mattson, Mark P ^b,c  

^a Mitochon Pharmaceuticals Inc   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BDNF; CREB; DNP; Hormesis; Mitochondrial uncoupling; Parkinson's disease; Synaptic plasticity

Indexed keywords

2,4 DINITROPHENOL; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; UNCOUPLING PROTEIN; UNCOUPLING PROTEIN 1;

ALZHEIMER DISEASE; AUTOPHAGY; BODY WEIGHT; BRAIN ISCHEMIA; CELL STRESS; EPILEPSY; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OXIDATIVE PHOSPHORYLATION UNCOUPLING; PARKINSON DISEASE; PRIORITY JOURNAL; SHORT SURVEY; ANIMAL; DEGENERATIVE DISEASE; DISEASE MODEL; HUMAN; METABOLISM; PHYSIOLOGY;

2,4-DINITROPHENOL; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; HUMANS; NEURODEGENERATIVE DISEASES; NEURONAL PLASTICITY; NEUROPROTECTION; UNCOUPLING PROTEIN 1;

EID: 85000538811     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2016.08.001     Document Type: Short Survey

References (101)

1. [1] Mattson, M.P., Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metab 16 (2012), 706–722.
2. [2] Barnard, N.D., Bush, A.I., Ceccarelli, A., Cooper, J., de Jager, C.A., Erickson, K.I., et al. Dietary and lifestyle guidelines for the prevention of Alzheimer's disease. Neurobiol Aging 35 (2014), S74–S78.
3. [3] Yaffe, K., Hoang, T.D., Byers, A.L., Barnes, D.E., Friedl, K.E., Lifestyle and health-related risk factors and risk of cognitive aging among older veterans. Alzheimers Dement 10 (2014), S111–S121.
4. [4] Mattson, M.P., Lifelong brain health is a lifelong challenge: from evolutionary principles to empirical evidence. Ageing Res Rev 20 (2015), 37–45.
5. [5] Duan, W., Mattson, M.P., Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J Neurosci Res 57 (1999), 195–206.
6. [6] Halagappa, V.K., Guo, Z., Pearson, M., Matsuoka, Y., Cutler, R.G., Laferla, F.M., et al. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol Dis 26 (2007), 212–220.
7. [7] Ploughman, M., Attwood, Z., White, N., Doré, J.J., Corbett, D., Endurance exercise facilitates relearning of forelimb motor skill after focal ischemia. Eur J Neurosci 25 (2007), 3453–3460.
8. [8] Yuede, C.M., Zimmerman, S.D., Dong, H., Kling, M.J., Bero, A.W., Holtzman, D.M., et al. Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease. Neurobiol Dis 35 (2009), 426–432.
9. [9] Tapia-Rojas, C., Aranguiz, F., Varela-Nallar, L., Inestrosa, N.C., Voluntary running attenuates memory loss, decreases neuropathological changes and induces neurogenesis in a mouse model of Alzheimer's disease. Brain Pathol 26 (2016), 62–74.
10. [10] Arumugam, T.V., Phillips, T.M., Cheng, A., Morrell, C.H., Mattson, M.P., Wan, R., Age and energy intake interact to modify cell stress pathways and stroke outcome. Ann Neurol 67 (2010), 41–52.
11. [11] Zigmond, M.J., Smeyne, R.J., Exercise: is it a neuroprotective and if so, how does it work?. Parkinsonism Relat Disord 20 (2014), S123–S127.
12. [12] Akinyemi, R.O., Mukaetova-Ladinska, E.B., Attems, J., Ihara, M., Kalaria, R.N., Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia. Curr Alzheimer Res 10 (2013), 642–653.
13. [13] Geisler, J.G., Targeting energy expenditure via fuel switching and beyond. Diabetologia 54 (2011), 237–244.
14. [14] Stranahan, A.M., Mattson, M.P., Recruiting adaptive cellular stress responses for successful brain ageing. Nat Rev Neurosci 13 (2012), 209–216.
15. [15] Mattson, M.P., Meffert, M.K., Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ 13 (2006), 852–860.
16. [16] Ghosh, N., Ghosh, R., Mandal, S.C., Antioxidant protection: a promising therapeutic intervention in neurodegenerative disease. Free Radic Res 45 (2011), 888–905.
17. [17] Cohen, S.M., Li, B., Tsien, R.W., Ma, H., Evolutionary and functional perspectives on signaling from neuronal surface to nucleus. Biochem Biophys Res Commun 460 (2015), 88–99.
18. [18] Marosi, K., Mattson, M.P., BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol Metab 25 (2014), 89–98.
19. [19] Yang, J.L., Lin, Y.T., Chuang, P.C., Bohr, V.A., Mattson, M.P., BDNF and exercise enhance neuronal DNA repair by stimulating CREB-mediated production of apurinic/apyrimidinic endonuclease 1. Neuromolecular Med 16 (2014), 161–174.
20. [20] Cheng, A., Yang, Y., Zhou, Y., Maharana, C., Lu, D., Peng, W., et al. Mitochondrial SIRT3 mediates adaptive responses of neurons to exercise and metabolic and excitatory challenges. Cell Metab 23 (2016), 128–142.
21. [21] Alirezaei, M., Kemball, C.C., Flynn, C.T., Wood, M.R., Whitton, J.L., Kiosses, W.B., Short-term fasting induces profound neuronal autophagy. Autophagy 6 (2010), 702–710.
22. [22] Pallanck, L.J., Culling sick mitochondria from the herd. J Cell Biol 191 (2011), 1225–1227.
23. [23] Calabrese, E.J., Bachmann, K.A., Bailer, A.J., Bolger, P.M., Borak, J., Cai, L., et al. Biological stress response terminology: integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol 222 (2007), 122–128.
24. [24] Lee, J., Bruce-Keller, A.J., Kruman, Y., Chan, S.L., Mattson, M.P., 2-Deoxy-D-glucose protects hippocampal neurons against excitotoxic and oxidative injury: evidence for the involvement of stress proteins. J Neurosci Res 57 (1999), 48–61.
25. [25] Yu, Z.F., Mattson, M.P., Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J Neurosci Res 57 (1999), 830–839.
26. [26] Mattson, M.P., Gleichmann, M., Cheng, A., Mitochondria in neuroplasticity and neurological disorders. Neuron 60 (2008), 748–766.
27. [27] Hongpaisan, J., Winters, C.A., Andrews, S.B., Strong calcium entry activates mitochondrial superoxide generation, upregulating kinase signaling in hippocampal neurons. J Neurosci 24 (2004), 10878–10887.
28. [28] Li, Z., Ji, G., Neugebauer, V., Mitochondrial reactive oxygen species are activated by mGluR5 through IP3 and activate ERK and PKA to increase excitability of amygdala neurons and pain behavior. J Neurosci 31 (2011), 1114–1127.
29. [29] Cheng, A., Wan, R., Yang, J.L., Kamimura, N., Son, T.G., Ouyang, X., et al. Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines. Nat Commun, 3, 2012, 1250.
30. [30] Formentini, L., Pereira, M.P., Sánchez-Cenizo, L., Santacatterina, F., Lucas, J.J., Navarro, C., et al. In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning. EMBO J 33 (2014), 762–778.
31. [31] Dirnagl, U., Meisel, A., Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning?. Neuropharmacology 55 (2008), 334–344.
32. [32] Golozoubova, V., Hohtola, E., Matthias, A., Jacobsson, A., Cannon, B., Nedergaard, J., Only UCP1 can mediate adaptive nonshivering thermogenesis in the cold. FASEB J 15 (2001), 2048–2050.
33. [33] Giralt, M., Villarroya, F., Mitochondrial uncoupling and the regulation of glucose homeostasis. Curr Diabetes Rev, 2016 [Epub ahead of print].
34. [34] Andrews, Z.B., Diano, S., Horvath, T.L., Mitochondrial uncoupling proteins in the CNS: in support of function and survival. Nat Rev Neurosci 6 (2005), 829–840.
35. [35] Liu, D., Chan, S.L., de Souza-Pinto, N.C., Slevin, J.R., Wersto, R.P., Zhan, M., et al. Mitochondrial UCP4 mediates an adaptive shift in energy metabolism and increases the resistance of neurons to metabolic and oxidative stress. Neuromolecular Med 8 (2006), 389–414.
36. [36] Rim, J.S., Kozak, L.P., Regulatory motifs for CREB-binding protein and Nfe2l2 transcription factors in the upstream enhancer of the mitochondrial uncoupling protein 1 gene. J Biol Chem 277 (2002), 34589–34600.
37. [37] Bengtson, C.P., Bading, H., Nuclear calcium signaling. Adv Exp Med Biol 970 (2012), 377–405.
38. [38] Mattiasson, G., Shamloo, M., Gido, G., Mathi, K., Tomasevic, G., Yi, S., et al. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat Med 9 (2003), 1062–1068.
39. [39] da Costa, R.F., Martinez, A.M., Ferreira, S.T., 2,4-Dinitrophenol blocks neurodegeneration and preserves sciatic nerve function after trauma. J Neurotrauma 27 (2010), 829–841.
40. [40] Liu, Y., Chen, L., Xu, X., Vicaut, E., Sercombe, R., Both ischemic preconditioning and ghrelin administration protect hippocampus from ischemia/reperfusion and upregulated uncoupling protein 2. BMC Physiol, 9, 2009, 17.
41. [41] Sullivan, P.G., Dube, C., Dorenbos, K.D., Steward, O., Baram, T.Z., Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Ann Neurol 53 (2003), 711–717.
42. [42] Sullivan, P.G., Springer, J.E., Hall, E.D., Scheff, S.W., Mitochondrial uncoupling as a therapeutic target following neuronal injury. J Bioenerg Biomembr 36 (2004), 353–356.
43. [43] Mattiasson, G., Sullivan, P.G., The emerging roles of UCP2 in health and disease. Antioxid Redox Signal 8 (2006), 1–38.
44. [44] Vincent, A.M., Olzmann, J.A., Brownlee, M., Sivitz, W.I., Russell, J.W., Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death. Diabetes 53 (2004), 726–734.
45. [45] Conti, B., Sugama, S., Lucero, J., Winsky-Sommerer, R., Wirz, S.A., Maher, P., et al. Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl-tetrahydropyridine toxicity. J Neurochem 93 (2005), 493–501.
46. [46] Chu, A.C., Ho, P.W., Kwok, K.H., Ho, J.W., Chan, K.H., Liu, H.F., et al. Mitochondrial UCP4 attenuates MPP+ - and dopamine-induced oxidative stress, mitochondrial depolarization, and ATP deficiency in neurons and is interlinked with UCP2 expression. Free Radic Biol Med 46 (2009), 810–820.
47. [47] Kwok, K.H., Ho, P.W., Chu, A.C., Ho, J.W., Liu, H.F., Yiu, D.C., et al. Mitochondrial UCP5 is neuroprotective by preserving mitochondrial membrane potential, ATP levels, and reducing oxidative stress in MPP+ and dopamine toxicity. Free Radic Biol Med 49 (2010), 1023–1035.
48. [48] Mattson, M.P., Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med 3 (2003), 65–94.
49. [49] Chan, S.L., Liu, D., Kyriazis, G.A., Bagsiyao, P., Ouyang, X., Mattson, M.P., Mitochondrial uncoupling protein-4 regulates calcium homeostasis and sensitivity to store depletion-induced apoptosis in neural cells. J Biol Chem 281 (2006), 37391–37403.
50. [50] Bondarenko, A.I., Parichatikanond, W., Madreiter, C.T., Rost, R., Waldeck-Weiermair, M., Malli, R., et al. UCP2 modulates single-channel properties of a MCU-dependent Ca(2+) inward current in mitochondria. Pflugers Arch 467 (2015), 2509–2518.
51. [51] Hwang, R.D., Wiemerslage, L., LaBreck, C.J., Khan, M., Kannan, K., Wang, X., et al. The neuroprotective effect of human uncoupling protein 2 (hUCP2) requires cAMP-dependent protein kinase in a toxin model of Parkinson's disease. Neurobiol Dis 69 (2014), 180–191.
52. [52] Davis, L.M., Rho, J.M., Sullivan, P.G., UCP-mediated free fatty acid uncoupling of isolated cortical mitochondria from fasted animals: correlations to dietary modulations. Epilepsia 49 (2008), 117–119.
53. [53] Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98 (1999), 115–124.
54. [54] Pratico, D., Uryu, K., Leight, S., Trojanoswki, J.Q., Lee, V.M., Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21 (2001), 4183–4187.
55. [55] Kowaltowski, A.J., de Souza-Pinto, N.C., Castilho, R.F., Vercesi, A.E., Mitochondria and reactive oxygen species. Free Radic Biol Med 47 (2009), 333–343.
56. [56] Liu, D., Zhang, Y., Gharavi, R., Park, H.R., Lee, J., Siddiqui, S., et al. The mitochondrial uncoupler DNP triggers brain cell mTOR signaling network reprogramming and CREB pathway up-regulation. J Neurochem 134 (2015), 677–692.
57. [57] Bernardi, P., Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev 79 (1999), 1127–1155.
58. [58] Stutzmann, G.E., Mattson, M.P., Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease. Pharmacol Rev 63 (2011), 700–727.
59. [59] Minners, J., van den Bos, E.J., Yellon, D.M., Schwalb, H., Opie, L.H., Sack, M.N., Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection. Cardiovasc Res 47 (2000), 68–73.
60. [60] Hausenloy, D., Wynne, A., Duchen, M., Yellon, D., Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation 109 (2004), 1714–1717.
61. [61] Korde, A.S., Pettigrew, L.C., Craddock, S.D., Maragos, W.F., The mitochondrial uncoupler 2,4-dinitrophenol attenuates tissue damage and improves mitochondrial homeostasis following transient focal cerebral ischemia. J Neurochem 94 (2005), 1676–1684.
62. [62] Righi, V., Constantinou, C., Mintzopoulos, D., Khan, N., Mupparaju, S.P., Rahme, L.G., et al. Mitochondria-targeted antioxidant promotes recovery of skeletal muscle mitochondrial function after burn trauma assessed by in vivo 31P nuclear magnetic resonance and electron paramagnetic resonance spectroscopy. FASEB J 27 (2013), 2521–2530.
63. [63] Wu, Y.N., Munhall, A.C., Johnson, S.W., Mitochondrial uncoupling agents antagonize rotenone actions in rat substantia nigra dopamine neurons. Brain Res 1395 (2011), 86–93.
64. [64] Wasilewska-Sampaio, A.P., Silveira, M.S., Holub, O., Goecking, R., Gomes, F.C., Neto, V.M., et al. Neuritogenesis and neuronal differentiation promoted by 2,4-dinitrophenol, a novel anti-amyloidogenic compound. FASEB J 19 (2005), 1627–1636.
65. [65] Liu, D., Lu, C., Wan, R., Auyeung, W.W., Mattson, M.P., Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. J Cereb Blood Flow Metab 22 (2002), 431–443.
66. [66] Pandya, J.D., Pauly, J.R., Nukala, V.N., Sebastian, A.H., Day, K.M., Korde, A.M., et al. Mitochondrial uncouplers as possible therapeutic interventions following traumatic brain injury. J Neurotrauma 24 (2007), 798–811.
67. [67] Pandya, J.D., Pauly, J.R., Sullivan, P.G., The optimal dosage and window of opportunity to maintain mitochondrial homeostasis following traumatic brain injury using the uncoupler FCCP. Exp Neurol 218 (2009), 381–389.
68. [68] Weisová, P., Anilkumar, U., Ryan, C., Concannon, C.G., Prehn, J.H., Ward, M.W., Mild mitochondrial uncoupling’ induced protection against neuronal excitotoxicity requires AMPK activity. Biochim Biophys Acta 1817 (2012), 744–753.
69. [69] Brennan, J.P., Southworth, R., Medina, R.A., Davidson, S.M., Duchen, M.R., Shattock, M.J., Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation. Cardiovasc Res 72 (2006), 313–321.
70. [70] Liu, D., Pitta, M., Lee, J.H., Ray, B., Lahiri, D.K., Furukawa, K., et al. The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease. J Alzheimers Dis 22 (2010), 443–457.
71. [71] Holmuhamedov, E.L., Jahangir, A., Oberlin, A., Komarov, A., Colombini, M., Terzic, A., Potassium channel openers are uncoupling protonophores: implication in cardioprotection. FEBS Lett 568 (2004), 167–170.
72. [72] Alemzadeh, R., Karlstad, M.D., Tushaus, K., Buchholz, M., Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats. Metabolism 57 (2008), 1597–1607.
73. [73] Vaynman, S., Ying, Z., Wu, A., Gomez-Pinilla, F., Coupling energy metabolism with a mechanism with a mechanism to support brain-derived neurotrophic factor-mediated synaptic plasticity. Neuroscience 139 (2006), 1221–1234.
74. [74] Dietrich, M.O., Andrews, Z.B., Horvath, T.L., Exercise-induced synaptogenesis in the hippocampus is dependent on UCP2-regulated mitochondrial adaptation. J Neurosci 28 (2008), 10766–10771.
75. [75] Varela, L., Schwartz, M.L., Horvath, T.L., Mitochondria controlled by UCP2 determine hypoxia-induced synaptic remodeling in the cortex and hippocampus. Neurobiol Dis 90 (2016), 68–74.
76. [76] Sullivan, P.G., Rippy, N.A., Rho, J.M., The ketogenic diet increases mitochondrial uncoupling protein levels and activity in mouse hippocampus. Ann Neurol 55 (2004), 576–580.
77. [77] Meyer, R., Patel, A.M., Rattana, S.K., Quock, T.P., Mody, S.H., Prescription opioid abuse: a literature review of the clinical and economic burden in the United States. Popul Health Manag 17 (2014), 372–387.
78. [78] Jones, C.M., McAninch, J.K., Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines. Am J Prev Med 49 (2015), 493–501.
79. [79] Charlson, F., Degenhardt, L., McLaren, J., Hall, W., Lynskey, M., A systematic review of research examining benzodiazepine-related mortality. Pharmacoepidemiol Drug Saf 18 (2009), 93–103.
80. [80] Jabbar, S.B., Hanly, M.G., Fatal caffeine overdose: a case report and review of literature. Am J Forensic Med Pathol 34 (2013), 321–324.
81. [81] Link, K.P., The discovery of dicumarol and its sequels. Circulation 19 (1959), 97–107.
82. [82] Holmes, R.W., Love, J., Suicide attempt with warfarin, a bishydroxycoumarin-like rodenticide. J Am Med Assoc 148 (1952), 935–937.
83. [83] Pollock, B.E., Clinical experience with warfarin (coumadin) sodium, a new anticoagulant. J Am Med Assoc 159 (1955), 1094–1097.
84. [84] Jarvik, L.F., Congenital malformations attributed to sleeping pill (Thalidomide). Eugen Q 9 (1962), 95–97.
85. [85] Palumbo, A., Facon, T., Sonneveld, P., Bladè, J., Offidani, M., Gay, F., et al. Thalidomide for treatment of multiple myeloma: 10 years later. Blood 111 (2008), 3968–3977.
86. [86] Perkins, R.G., A study of munitions intoxications in France. Public Health Rep 34 (1919), 2335–2374.
87. [87] Cutting, W.C., Mehrtens, H.G., Tainter, M.L., Actions and uses of dinitrophenol. Promising metabolic applications. JAMA, 101, 1933, 193.
88. [88] Tainter, M.L., Cutting, W.C., Stockton, A.B., Use of dinitrophenol in nutritional disorders: a critical survey of clinical results. Am J Public Health Nations Health 24 (1934), 1045–1053.
89. [89] Horner, W.D., A study of dinitrophenol and its relation to cataract formation. Trans Am Ophthalmol Soc 39 (1941), 405–437.
90. [90] Petróczi, A., Ocampo, J.A., Shah, I., Jenkinson, C., New, R., James, R.A., et al. Russian roulette with unlicensed fat-burner drug 2,4-dinitrophenol (DNP): evidence from a multidisciplinary study of the internet, bodybuilding supplements and DNP users. Subst Abuse Treat Prev Policy, 10, 2015, 39.
91. [91] Goldgof, M., Xiao, C., Chanturiya, T., Jou, W., Gavrilova, O., Reitman, M.L., The chemical uncoupler 2,4-dinitrophenol (DNP) protects against diet-induced obesity and improves energy homeostasis in mice at thermoneutrality. J Biol Chem 289 (2014), 19341–19350.
92. [92] Rolfe, D.F., Brand, M.D., Contribution of mitochondrial proton leak to skeletal muscle respiration and to standard metabolic rate. Am J Physiol 271 (1996), C1380–C1389.
93. [93] Nicholls, D.G., Bernson, V.S., Heaton, G.M., The identification of the component in the inner membrane of brown adipose tissue mitochondria responsible for regulating energy dissipation. Experientia Suppl 32 (1978), 89–93.
94. [94] Perry, R.J., Zhang, D., Zhang, X.M., Boyer, J.L., Shulman, G.I., Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats. Science 347 (2015), 1253–1256.
95. [95] Perry, R.J., Kim, T., Zhang, X.M., Lee, H.Y., Pesta, D., Popov, V.B., et al. Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targetedmitochondrial uncoupler. Cell Metab 18 (2013), 740–748.
96. [96] Caldeira da Silva, C.C., Cerqueira, F.M., Barbosa, L.F., Medeiros, M.H., Kowaltowski, A.J., Mild mitochondrial uncoupling in mice affects energy metabolism, redox balance and longevity. Aging Cell 7 (2008), 552–560.
97. [97] Sebollela, A., Freitas-Corrêa, L., Oliveira, F.F., Mendes, C.T., Wasilewska-Sampaio, A.P., Camacho-Pereira, J., et al. Expression profile of rat hippocampal neurons treated with the neuroprotective compound 2,4-dinitrophenol: up-regulation of cAMP signaling genes. Neurotox Res 18 (2010), 112–123.
98. [98] De Felice, F.G., Ferreira, S.T., Novel neuroprotective, neuritogenic and anti-amyloidogenic properties of 2,4-dinitrophenol: the gentle face of Janus. IUBMB Life 58 (2006), 185–191.
99. [99] Duan, W., Guo, Z., Mattson, M.P., Brain-derived neurotrophic factor mediates an excitoprotective effect of dietary restriction in mice. J Neurochem 76 (2001), 619–626.
100. [100] Morrison, R.S., Wenzel, H.J., Kinoshita, Y., Robbins, C.A., Donehower, L.A., Schwartzkroin, P.A., Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci 16 (1996), 1337–1345.
101. [101] Kashiwaya, Y., Bergman, C., Lee, J.H., Wan, R., King, M.T., Mughal, M.R., et al. A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease. Neurobiol Aging 34 (2013), 1530–1539.